CannBioRx Life Sciences Corp. (ATNFW)
USD 0.01
(5.63%)
USD 0.01
(5.63%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 19.93 Thousand USD | -36.08% |
| 2022 | 31.18 Thousand USD | -35.25% |
| 2021 | 48.16 Thousand USD | -57.66% |
| 2020 | 113.76 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 13.28 Thousand USD | -19.67% |
| 2024 Q1 | 16.54 Thousand USD | -17.01% |
| 2023 FY | 19.93 Thousand USD | -36.08% |
| 2023 Q2 | 26.31 Thousand USD | -8.42% |
| 2023 Q1 | 28.73 Thousand USD | -7.88% |
| 2023 Q3 | 22.21 Thousand USD | -15.57% |
| 2023 Q4 | 19.93 Thousand USD | -10.26% |
| 2022 Q3 | 31.52 Thousand USD | -15.59% |
| 2022 Q4 | 31.18 Thousand USD | -1.06% |
| 2022 Q2 | 37.34 Thousand USD | -14.36% |
| 2022 Q1 | 43.6 Thousand USD | -9.46% |
| 2022 FY | 31.18 Thousand USD | -35.25% |
| 2021 FY | 48.16 Thousand USD | -57.66% |
| 2021 Q1 | 107.96 Thousand USD | -5.1% |
| 2021 Q2 | 70.02 Thousand USD | -35.14% |
| 2021 Q3 | 52.09 Thousand USD | -25.6% |
| 2021 Q4 | 48.16 Thousand USD | -7.55% |
| 2020 Q4 | 113.76 Thousand USD | 0.0% |
| 2020 Q3 | - USD | -100.0% |
| 2020 Q2 | 2.8 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 113.76 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| BIMI International Medical Inc. | 2.88 Million USD | 99.31% |
| China Jo-Jo Drugstores, Inc. | 6.4 Million USD | 99.689% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 183.17 Million USD | 99.989% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 183.17 Million USD | 99.989% |
| Leafly Holdings, Inc. | 29.08 Million USD | 99.931% |
| Leafly Holdings, Inc. | 29.08 Million USD | 99.931% |
| LifeMD, Inc. | 17.92 Million USD | 99.889% |
| LifeMD, Inc. | 17.92 Million USD | 99.889% |
| TRxADE HEALTH, Inc. | 434.2 Thousand USD | 95.409% |
| PetMed Express, Inc. | 995 Thousand USD | 97.996% |
| Walgreens Boots Alliance, Inc. | 8.04 Billion USD | 100.0% |